Difference between revisions of "Citalopram-paroxetine"

From Psychiatrienet
Jump to: navigation, search
Line 10: Line 10:
 
| info =  
 
| info =  
 
* The same applies to [[escitalopram]].
 
* The same applies to [[escitalopram]].
 +
* {{theorSS}}
 
}}
 
}}

Revision as of 16:00, 6 August 2009

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
paroxetine
Type Antidepressant
Group SSRI
links
Medscape paroxetine
PubChem 43815
PubMed paroxetine
Kompas (Dutch) paroxetine
Wikipedia paroxetine

Switch medication from citalopram to paroxetine.[1] [2]

Nietinrijdenbord.png Stop citalopram
  • Gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
  • When a dosage of 20 mg/day, resp. 10 mg/day, is reached, stop administration.
Eenrichtingbord.png Start paroxetine
  • No wash-out period is needed.
  • Start paroxetine the next day in normal dosage of 20 mg/day.
Infobord.png More information
  • The same applies to escitalopram.
  • Occurrence of the serotonin syndrome is not likely, but theoretically possible, so caution is necessary.
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.